Login
$CNVS
$1.45 -$0.03 (2.36%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
Current Assets
Cash and cash equivalents
Accounts receivable, net of allowance for credit losses of $657 and $622, respectively
Unbilled revenue
Employee retention tax credit
Content advances, net allowance of $5,768 and $5,503, respectively
Other current assets
Total current assets
Equity investment in Metaverse, a related party, at fair value
Property and equipment, net
Intangible assets, net
Goodwill
Content advances, net of current portion
Other long-term assets, net
Total Assets
Current Liabilities
Accounts payable and accrued expenses
Line of credit, net
Deferred consideration
Current portion of deferred consideration
Term Loan, including unamortized debt issuance costs of $131 and $0, respectively
Earnout consideration on purchase of business
Current portion of earnout consideration
Current portion of operating lease liabilities
Other current liabilities
Deferred revenue
Total current liabilities
Deferred consideration on purchase of business, net of current portion
Operating lease liabilities, net of current portion
Convertible notes payable, net
Earnout consideration, net of current portion
Other long-term liabilities
Total Liabilities
Stockholders' Equity
Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; 6 and 7 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively
Common stock, $0.001 par value; Class A Stock: 275,000,000 shares authorized as of June 30, 2026 and March 31, 2026; 24,247,336 and 21,362,845 shares issued, with 23,417,021 and 20,532,531 shares outstanding as of June 30, 2026 and March 31, 2026, respectively
Additional paid-in capital
Treasury stock, at cost; with 830,315 shares as of June 30, 2026 and March 31, 2026, respectively
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity of Cineverse Corp.
Deficit attributable to noncontrolling interest
Total stockholders' equity
Total Liabilities and Stockholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support